Case Series: Genetic mimics of hypertrophic cardiomyopathy in elderly

Olga S Chumakova1,2, Olga A Drobyazko2, Elena A Stepanova3

  • 1Cardiological Department, Moscow City Clinical Hospital No. 17, Moscow, Russia.

Insights

Hypertrophic cardiomyopathy mimics can be challenging to diagnose, especially in older adults. Genetic testing is crucial for identifying rare conditions like amyloidosis, Fabry disease, and desminopathy, enabling accurate diagnosis and tailored treatments.

Area of Science:

  • Cardiology
  • Genetics
  • Rare Diseases

Background:

  • Hypertrophic cardiomyopathy (HCM) is a common genetic heart disorder caused by sarcomeric protein variants.
  • A significant percentage of patients with HCM phenotypes may have other underlying genetic conditions.
  • Diagnosing these HCM mimics can be difficult, particularly in elderly patients due to subtle extracardiac signs.

Observation:

  • This study details three cases mimicking HCM: TTR p.V50M amyloidosis, GLA p.N215S Fabry disease, and DES p.R355* desminopathy.
  • Clinical presentation in elderly individuals can obscure underlying syndromic diseases.
  • Genetic testing is vital for differentiating HCM from its mimics.

Findings:

  • Comprehensive genetic and clinical data were collected for three distinct HCM mimic cases.
  • Specific pathogenic nucleotide variants (PNVs) were identified in TTR, GLA, and DES genes.
  • The study highlights the diagnostic challenges posed by these rare hereditary conditions.

Implications:

  • Accurate genetic diagnosis of HCM mimics is essential for appropriate patient management and treatment.
  • Early identification allows for targeted therapies and screening of at-risk family members.
  • Understanding these mimics improves diagnostic strategies for complex cardiac phenotypes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
64
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
40
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
42